Cryoport Stock Forecast, Price & News

Cryoport (NASDAQ:CYRX) Frequently Asked Questions

Is Cryoport a buy right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cryoport stock.
View analyst ratings for Cryoport or view top-rated stocks.

How has Cryoport's stock price been impacted by COVID-19?

Cryoport's stock was trading at $16.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CYRX shares have increased by 151.3% and is now trading at $41.77.
View which stocks have been most impacted by COVID-19.

When is Cryoport's next earnings date?

Cryoport is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022.
View our earnings forecast for Cryoport.

How were Cryoport's earnings last quarter?

Cryoport, Inc. (NASDAQ:CYRX) announced its earnings results on Thursday, November, 4th. The consumer goods maker reported ($0.18) EPS for the quarter, missing the Zacks' consensus estimate of ($0.15) by $0.03. The consumer goods maker earned $56.69 million during the quarter, compared to analyst estimates of $54.44 million. Cryoport had a negative net margin of 12.57% and a positive trailing twelve-month return on equity of 2.67%. The business's revenue for the quarter was up 407.5% on a year-over-year basis. During the same period last year, the firm posted ($0.29) earnings per share.
View Cryoport's earnings history.

What price target have analysts set for CYRX?

7 brokers have issued twelve-month price objectives for Cryoport's stock. Their forecasts range from $75.00 to $95.00. On average, they anticipate Cryoport's share price to reach $87.14 in the next twelve months. This suggests a possible upside of 108.6% from the stock's current price.
View analysts' price targets for Cryoport or view top-rated stocks among Wall Street analysts.

Who are Cryoport's key executives?

Cryoport's management team includes the following people:

• Jerrell W. Shelton, Chairman, President & Chief Executive Officer (LinkedIn Profile)
• Phil Wilson, Chief Operating Officer
• Robert S. Stefanovich, Chief Financial Officer, Secretary & Treasurer (LinkedIn Profile)
• Bret Bollinger, Chief Technology Officer
• Mark W. Sawicki, Chief Scientific Officer (LinkedIn Profile)

Who are some of Cryoport's key competitors?

Some companies that are related to Cryoport include Biohaven Pharmaceutical (BHVN), Evotec (EVTCY), Maravai LifeSciences (MRVI), Ascendis Pharma A/S (ASND), Legend Biotech (LEGN), Mirati Therapeutics (MRTX), Arena Pharmaceuticals (ARNA), Sarepta Therapeutics (SRPT), Arrowhead Pharmaceuticals (ARWR), Perrigo (PRGO), HUTCHMED (HCM), Zai Lab (ZLAB), Ultragenyx Pharmaceutical (RARE), Ionis Pharmaceuticals (IONS) and Blueprint Medicines (BPMC).
View all of CYRX's competitors.

What other stocks do shareholders of Cryoport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Square (SQ).

What is Cryoport's stock symbol?

Cryoport trades on the NASDAQ under the ticker symbol "CYRX."

Who are Cryoport's major shareholders?

Cryoport's stock is owned by many different retail and institutional investors. Top institutional shareholders include Rheos Capital Works Inc. (0.33%), Spence Asset Management (0.30%), Penbrook Management LLC (0.07%), Russell Investments Group Ltd. (0.04%), Foundations Investment Advisors LLC (0.01%) and Parallel Advisors LLC (0.01%). Company insiders that own Cryoport stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman and Robert Stefanovich.
View institutional ownership trends for Cryoport.

Which institutional investors are selling Cryoport stock?

CYRX stock was sold by a variety of institutional investors in the last quarter, including Penbrook Management LLC, Foundations Investment Advisors LLC, and Cutler Group LP. Company insiders that have sold Cryoport company stock in the last year include Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, and Robert Stefanovich.
View insider buying and selling activity for Cryoport or view top insider-selling stocks.

Which institutional investors are buying Cryoport stock?

CYRX stock was acquired by a variety of institutional investors in the last quarter, including Rheos Capital Works Inc., Spence Asset Management, Russell Investments Group Ltd., Parallel Advisors LLC, and Lindbrook Capital LLC.
View insider buying and selling activity for Cryoport or or view top insider-buying stocks.

How do I buy shares of Cryoport?

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cryoport's stock price today?

One share of CYRX stock can currently be purchased for approximately $41.77.

How much money does Cryoport make?

Cryoport has a market capitalization of $1.93 billion and generates $78.70 million in revenue each year. The consumer goods maker earns $-32.69 million in net income (profit) each year or ($1.79) on an earnings per share basis.

How many employees does Cryoport have?

Cryoport employs 610 workers across the globe.

What is Cryoport's official website?

The official website for Cryoport is www.cryoport.com.

Where are Cryoport's headquarters?

Cryoport is headquartered at 112 Westwood Place Suite 350, Brentwood TN, 37027.

How can I contact Cryoport?

Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The consumer goods maker can be reached via phone at (949) 470-2300, via email at [email protected], or via fax at 949-470-2306.